1-ethyl-2-benzimidazolinone has been researched along with serine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schlichter, LC; Wong, R | 1 |
1 other study(ies) available for 1-ethyl-2-benzimidazolinone and serine
Article | Year |
---|---|
PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Topics: Animals; Animals, Newborn; Benzimidazoles; Calcium; Calcium Channel Agonists; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cells, Cultured; Enzyme Inhibitors; Female; HEK293 Cells; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Protein Binding; Protein Kinases; Rats; Rats, Sprague-Dawley; Serine | 2014 |